Statin intolerance is ‘over-estimated and over-diagnosed’
As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other… read more.
As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other… read more.
Communities in the North West of England experienced more than three times the excess years of life lost in the South West. The impact of the COVID-19 pandemic… read more.
A study published in Science Translational Medicine performed at the Latner Thoracic Surgery Research Laboratories and UHN’s Ajmera Transplant Centre has proved that it is possible to convert… read more.
Critically ill COVID-19 patients already on mechanical ventilation or extracorporeal membrane oxygenation have achieved a significantly higher rate of survival when randomized to receive baricitinib, a treatment for… read more.
For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes COVID-19, according… read more.
Daily moderate to vigorous physical activity of at least 20 minutes undertaken by persons in early old age (70-75 years) might be the best way to avoid, in… read more.
Acne on the face is often treated with topical antibiotics, which tend to be used for an extended period of time and contribute to the serious problem of… read more.
Following a severe stroke caused by artery-blocking clots, patients who undergo endovascular therapy (mechanical clot removal) plus standard medical therapy have fewer physical limitations 90 days post-stroke compared… read more.
The third wave of the COVID-19 pandemic in the summer of 2021 spread far faster in rural America, much of which has low rates of vaccination. A new… read more.
Incyte has announced that the FDA has approved Jakafi (ruxolitinib) for treatment of chronic graft-versus-host disease (GVHD) after failure of one or two lines of systemic therapy in… read more.
A young adult in the U.S. could add more than a decade to their life expectancy by changing their diet from a typical Western diet to an optimized… read more.
University of Illinois Chicago researchers have developed a compound that may one day offer hope for pancreatic cancer treatment. A pre-clinical study of the experimental compound shows that… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.